Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study to Demonstrate the Safety and Performance of the GARDEX™ Embolic Protection Device When Used During Percutaneous Coronary Intervention (PCI) of Saphenous Vein Graft

NCT01042444 is registered in ClinicalTrials.gov with Gardia Medical as lead sponsor.

NCT NCT01042444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study to Demonstrate the Safety and Performance of the GARDEX™ Embolic Protection Device When Used During Percutaneous Coronary Intervention (PCI) of Saphenous Vein Graft
Lead sponsor
Gardia Medical
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2009
Completion date
January 31, 2011
Enrollment
6 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

embolism, myocardial ischemia, saphenous vein graft disease